A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals

Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
12/2002
12/17/2002	US6495359 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
12/17/2002	US6495349 Chimeric gene constructs
12/17/2002	US6495325 Determining presence or absence of equilibrium in intestinal bacterial flora by comparing a restriction pattern of the amplificate to at least one reference restriction pattern
12/17/2002	US6494502 Connector for small animal cage systems
12/12/2002	WO2002099418A1 Premalignant, serially-transplantable breast tissue lines and uses thereof
12/12/2002	WO2002099108A2 Atp-binding cassette transporter-like molecules and uses thereof
12/12/2002	WO2002099099A2 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications
12/12/2002	WO2002099036A2 Inhibition of neurodegeneration
12/12/2002	WO2002098444A2 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
12/12/2002	WO2002098217A1 Method for targeting transcriptionally active loci
12/12/2002	WO2002098216A1 Animal model for allergy
12/12/2002	WO2002085306A3 Use of follistatin to increase muscle mass
12/12/2002	WO2002083891A3 Nucleic acids for inhibiting hairless protein expression and methods of use thereof
12/12/2002	WO2002046404A3 Schizophrenia-related voltage-gated ion channel gene and protein
12/12/2002	WO2002024749A3 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
12/12/2002	WO2001097607A3 Transgenic animal model of neurodegenerative disorders
12/12/2002	WO2001089568A9 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
12/12/2002	WO2001084921A9 Transgenic animal
12/12/2002	US20020188963 Embryonic stem cells for use in development of treatments for nervous system, cardiovascular and tumor disorders
12/12/2002	US20020188961 Non human transgenic animal in which the expression of the gene coding for insulin is deleted
12/12/2002	US20020187946 Mammalian iap gene family, primers, probes and detection methods
12/12/2002	US20020187549 Derivation of pluripotential embryonic cell lines from domestic animals
12/12/2002	US20020187523 Extracellular signaling molecules
12/12/2002	US20020187152 Administering a drug which can selectively kill Fusobacterium varium cells, or a drug which can neutralize the toxin produced by Fusobacterium varium cells; vaccines, diagnosis, screening
12/12/2002	US20020187140 Two novel human cathepsin proteins
12/12/2002	US20020187124 Asialocytokines and treatment of liver disease
12/12/2002	CA2449777A1 Animal model for allergy
12/12/2002	CA2449303A1 Method for targeting transcriptionally active loci
12/12/2002	CA2448382A1 Use of hepcidin as a regulator of iron homeostasis
12/12/2002	CA2430697A1 Atp-binding cassette transporter-like molecules and uses thereof
12/11/2002	EP1264889A1 Chicken leukemia inhibitory factor (LIF) and the gene thereof
12/11/2002	EP1263985A2 Methods for amplifying genetic material and uses thereof
12/11/2002	EP1263958A2 Nusap, a gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
12/11/2002	EP1263946A2 New qtl's on chromosomes x, 2, 6 and 7 of pigs
12/11/2002	EP1263767A2 Beta netrin and uses thereof
12/11/2002	EP1263521A2 A method of sorting cells
12/11/2002	EP1263284A1 Transgenic rodent comprising a polynucleotide encoding a human ucp3 polypeptide
12/11/2002	EP0956009B9 Treatment of neurodegenerative conditions with nimesulide
12/11/2002	CN1384882A Fatty acid desaturase gene from plants
12/11/2002	CN1384759A Single-stranded oligodeoxynucleotide mutional vectors
12/11/2002	CN1095630C Method for culturing Fuxing crucian carp
12/10/2002	US6493641 Methods and apparatus for customizing pet food
12/10/2002	US6492575 Method for developing transgenic mice
12/10/2002	US6492126 Compositions and methods for the treatment and diagnosis of cardiovascular disease
12/10/2002	US6491909 Blocking antigen expression in genes of the major histocompatibility complex to prevent graft versus host dieases after grafting islets of langerhans; prophylaxis of diabetes mellitus
12/10/2002	CA2239195C Ceramic packing with channels for thermal and catalytic beds
12/10/2002	CA2085127C Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease
12/05/2002	WO2002097395A2 P-cadherin as a target for anti-cancer therapy
12/05/2002	WO2002097110A2 TUMOR ENDOTHELIAL MARKER 7α MOLECULES AND USES THEREOF
12/05/2002	WO2002097094A1 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis
12/05/2002	WO2002097079A2 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene
12/05/2002	WO2002097059A2 Chromosome-based platforms
12/05/2002	WO2002097056A2 Method for generating replication defective viral vectors that are helper free
12/05/2002	WO2002097046A2 B7 related protein-2 molecules and uses thereof
12/05/2002	WO2002096951A1 Molecules for disease detection and treatment
12/05/2002	WO2002096195A1 Treatment or replacement therapy using transgenic stem cells delivered to the gut
12/05/2002	WO2002096192A2 Process of producing environmentally safe transgenic organisms
12/05/2002	WO2002077175A3 Method for generating cloned animals using chromosome shuffling
12/05/2002	WO2002070557A3 Nuclear hormone receptor ligand binding domain
12/05/2002	WO2002068470A3 Interferon-alpha induced gene
12/05/2002	WO2002060924A9 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds
12/05/2002	WO2002059150A3 Materials and methods relating to protein aggregation in neurodegenerative disease
12/05/2002	WO2002055666A3 Method for identifying genes involved in cell proliferation
12/05/2002	WO2002052244A3 Separation of x- and y-sperm cells
12/05/2002	WO2001079448A3 Trp8, a transient receptor potential channel expressed in taste receptor cells
12/05/2002	WO2001032685A9 Gene expression directed by a super-psa promoter
12/05/2002	US20020184656 In vivo assay system for screening and validation of drugs and other substances
12/05/2002	US20020184655 Generation of protein in urine that degrades or detoxifies preferential compounds; obtain transgenic animal, transform with vector that codes protein detectable in urine, express vector, recover protein
12/05/2002	US20020183275 Obtaining a large cloned genomic fragment; using bacterial homologous recombination to genetically modify to create a large targeting vector for use in eukaryotic cells (LTVEC); introducing LTVEC into eukaryotic cells; quantitative assay
12/05/2002	US20020182724 Expression vector for use tools in genome analysis and generation of transgenic animals
12/05/2002	US20020182698 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
12/05/2002	US20020182681 Peptide for use in treatment of cancer, parkinson's and metabolic disorders
12/05/2002	US20020182612 Diagnosing inflammatory defects in humans; obtain nucleotide sequence sample, incubate with probe associated with preferential allele, detect hybridization, hybridization indicates sensitivty to inflammatory defect
12/05/2002	CA2484900A1 Process of producing environmentally safe transgenic organisms
12/05/2002	CA2452707A1 Treatment or replacement therapy using transgenic stem cells delivered to the gut
12/05/2002	CA2449000A1 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis
12/05/2002	CA2448362A1 B7 related protein-2 molecules and uses thereof
12/05/2002	CA2448116A1 Molecules for disease detection and treatment
12/05/2002	CA2447916A1 Tumor endothelial marker 7.alpha. molecules and uses thereof
12/05/2002	CA2445611A1 P-cadherin as a target for anti-cancer therapy
12/05/2002	CA2441937A1 Chromosome-based platforms
12/04/2002	EP1261728A2 Plant internal ribosome entry segment
12/04/2002	EP1261707A1 5ht3 receptors of nematodes, polynucleotide molecules encoding same, and antagonists thereof
12/04/2002	EP1261639A2 Chondromodulin-i related peptide
12/04/2002	EP1261357A1 Isolation and transplantation of retinal stem cells
12/04/2002	EP1045702A4 Methods of controlling cell differentiation and growth using a fusion protein and a drug
12/04/2002	EP0625197B1 Dna encoding kappa-casein, process for obtaining the protein and use thereof
12/04/2002	CA2384907A1 Methods and compositions relating to mek5 and cardiac hypertrophy and dilated cardiomyopathy
12/03/2002	US6489536 Method for producing cloned bovines from cells of a bovine intramuscular preadipocyte cell line
12/03/2002	US6489535 Non-mammalian transgenic animal having an adult onset neurodegenerative phenotype
12/03/2002	US6489458 DNA-based transposon system for the introduction of nucleic acid into DNA of a cell
12/03/2002	US6489454 Phagocytosis or engulfment; protein known as ced-6 acts as an adaptor molecule in a signal transduction pathway that mediates the engulfment of apoptotic cells; nucleotide sequences, vectors, host cells
12/03/2002	US6489445 Polypeptides which specifically bind to at least one human bone morphogenic protein (bmp) selected from bmp-5 and bmp-6
12/03/2002	US6489127 Methods for identifying anti-cancer drug targets
12/03/2002	CA2126103C Transfection of lung via aerosolized transgene delivery
11/2002
11/28/2002	WO2002095068A2 Engineered secreted alkaline phosphatase (seap) reporter genes and polypeptides
11/28/2002	WO2002095003A2 Phytases, nucleic acids encoding them and methods for making and using them
11/28/2002	WO2002094997A2 Transcriptional regulation of target genes
11/28/2002	WO2002094876A2 Methods and compositions for treating respiratory mucin production associated disease conditions
11/28/2002	WO2002094874A2 Internalisation of virus into cells

1 ... 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 ... 341